Hemochromatosis Type 1 — Clinical Trials

MONDO:00210013 active·1 recruitingLast updated: Mar 20, 2026, 1:15 PM

Trial Landscape

Hemochromatosis Type 1 has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Industry2NIH1

Top Sponsors

Bond Biosciences

CSL Behring

Trial Locations

United States2 trials

Australia2 trials

Austria1 trial

Belgium1 trial

Canada1 trial

Czechia1 trial

Denmark1 trial

France1 trial

Germany1 trial

Ireland1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT07332091

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

Sponsor:CSL Behring

United StatesStarted: Feb 2026Est. completion: Apr 2028Updated: Jan 2026

Phase 1Not Yet Recruiting

NCT07371793

A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis

Sponsor:Bond Biosciences

AustraliaStarted: Mar 2026Est. completion: Feb 2027Updated: Jan 2026

Phase 2Active, Not Recruiting

NCT00007150

Treatment of Hemochromatosis

Sponsor:National Institutes of Health Clinical Center (CC)

United StatesStarted: Jan 2001Est. completion: Dec 2026Updated: Mar 2026

Stay informed about clinical trials for Hemochromatosis Type 1.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 1:15 PM